As of 2024-12-12, the EV/EBITDA ratio of Chordate Medical Holding publ AB (CMH.ST) is 0.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CMH.ST's latest enterprise value is -5.53 mil SEK. CMH.ST's TTM EBITDA according to its financial statements is -26.10 mil SEK. Dividing these 2 quantities gives us the above CMH.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 11.6x | 9.8x |
| Forward P/E multiples | 8.8x - 12.5x | 9.9x |
| Fair Price | (189.70) - (253.74) | (213.48) |
| Upside | -1510.4% - -1986.5% | -1687.2% |
| Date | EV/EBITDA |
| 2024-12-11 | 0.21 |
| 2024-12-10 | 0.21 |
| 2024-12-09 | 0.18 |
| 2024-12-06 | 0.20 |
| 2024-12-05 | 0.16 |
| 2024-12-04 | 0.11 |
| 2024-12-03 | 0.13 |
| 2024-12-02 | 0.04 |
| 2024-11-29 | 0.02 |
| 2024-11-28 | -0.02 |
| 2024-11-27 | -0.02 |
| 2024-11-26 | -0.02 |
| 2024-11-25 | -0.04 |
| 2024-11-22 | -0.08 |
| 2024-11-21 | -0.10 |
| 2024-11-20 | -0.10 |
| 2024-11-19 | -0.05 |
| 2024-11-18 | -0.08 |
| 2024-11-15 | -0.11 |
| 2024-11-14 | -0.13 |
| 2024-11-13 | -0.16 |
| 2024-11-12 | -0.17 |
| 2024-11-11 | -0.23 |
| 2024-11-08 | -0.24 |
| 2024-11-07 | -0.26 |
| 2024-11-06 | -0.24 |
| 2024-11-05 | -0.19 |
| 2024-11-04 | -0.24 |
| 2024-11-01 | -0.24 |
| 2024-10-31 | -0.23 |
| 2024-10-30 | -0.36 |
| 2024-10-29 | -0.36 |
| 2024-10-28 | -0.41 |
| 2024-10-25 | -0.46 |
| 2024-10-24 | -0.62 |
| 2024-10-23 | -0.77 |
| 2024-10-22 | -0.87 |
| 2024-10-21 | -0.86 |
| 2024-10-18 | -0.98 |
| 2024-10-17 | -1.01 |
| 2024-10-16 | -1.09 |
| 2024-10-15 | -0.80 |
| 2024-10-14 | -0.75 |
| 2024-10-11 | -0.57 |
| 2024-10-10 | -0.64 |
| 2024-10-09 | -0.62 |
| 2024-10-08 | -0.69 |
| 2024-10-07 | -0.57 |
| 2024-10-04 | -0.64 |
| 2024-10-03 | -0.74 |